Share-based compensation (Tables)

9 Months Ended

Sep. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Details of stock option activity during the nine months ended September 30, 2018 were as follows:



	Number of options		Weighted average exercise price per share		Weighted average remaining contractual term	Aggregate intrinsic value
Outstanding as of December 31, 2017	222,000		$	12.59	5.4 years	$	—
Expired	(110,000	)	$	11.17
Outstanding as of September 30, 2018	112,000		$	13.98	3.1 years	$	—
Options vested and expected to vest as of September 30, 2018	112,000		$	13.98	3.1 years	$	—
Options exercisable as of September 30, 2018	112,000		$	13.98	3.1 years	$	—

Unvested Balance of Options

The unvested balance of options is shown below for the nine months ended September 30, 2018:



	Number of options		Weighted average exercise price per share		Weighted average remaining contractual term
Unvested as of December 31, 2017	47,500		$	8.96	7.9 years
Vested (1)	(47,500	)	$	8.96
Unvested as of September 30, 2018	—		$	—	—

(1)As discussed in "Spin-off of red violet" above, the vesting of 47,500 shares of stock options was accelerated as a result of the Spin-off of red violet.

Schedule of Restricted Share Units, Common Stock Grants and Restricted Stock Activity

Details of unvested RSUs, common stock grants and restricted stock activity during the nine months ended September 30, 2018 were as follows:



	Number of units		Weighted average grant-date fair value
Unvested as of December 31, 2017	8,150,905		$	9.27
Granted (1)	4,565,125		$	2.63
Vested and delivered (2)	(11,462,280	)	$	7.63
Withheld as treasury stock (3)	(872,562	)	$	6.05
Vested not delivered (4)	3,766,068		$	9.85
Forfeited	(304,625	)	$	4.82
Unvested as of September 30, 2018	3,842,631		$	7.95

(1)As discussed in "Spin-off of red violet" above, among the RSUs granted during the nine months ended September 30, 2018, there were an aggregate of 304,000 shares of Spin-off Grants that vested and were delivered in the first quarter of 2018, and an aggregate of 2,041,000 shares of Transaction Grants that vested but were subject to deferred delivery over a three-year period.

(2)Among the shares vested and delivered during the nine months ended September 30, 2018, there were 6,278,318 shares that were vested but deferred from prior periods. See (4) below.

(3)As discussed in Note 8, the increase in treasury stock was due to shares withheld to cover statutory withholding taxes upon the vesting of RSUs during the first quarter of 2018. As of September 30, 2018, there were 1,225,085 outstanding shares of treasury stock.

(4)Vested not delivered represent vested RSUs or common stock grants with delivery deferred to a future time. During the nine months ended September 30, 2018, there was a net decrease of 3,766,068 shares included in vested not delivered, as a result of the delivery of common stock underlying RSUs included in "vested not delivered" in prior periods. As of September 30, 2018, there were 2,909,917 outstanding RSUs or shares of common stock grants included in vested not delivered.

Schedule of Share-based Compensation

The share-based compensation for the Company's stock options, RSUs, common stock grants and restricted stock were allocated to the following accounts in the condensed consolidated financial statements for the three and nine months ended September 30, 2018 and 2017:



	Three Months Ended September 30,				Nine Months Ended September 30,
(In thousands)	2018		2017		2018		2017
Sales and marketing expenses	$	728	$	1,024	$	2,203	$	2,428
General and administrative expenses	1,865		9,484		4,243		23,028
Spin-off transaction costs	—		—		5,409		—
Discontinued operations	—		563		15,713		2,246
	2,593		11,071		27,568		27,702
Capitalized in intangible assets of continuing operations	81		185		364		373
Capitalized in intangible assets of discontinued operations	—		236		181		629
Total	$	2,674	$	11,492	$	28,113	$	28,704